Extensive telangiectasias and mongolian spots: A clue towards GM1-gangliosidosis

Extensive telangiectasias and mongolian spots: A clue towards GM1-gangliosidosis

Bibliographic Details
Main Authors:	Sachin Gupta, Varniraj Patel, Shivangi Garg, Nikhil Mehta
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Journal of Dermatology
Online Access:	http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=5;spage=573;epage=574;aulast=Gupta

Similar Items

Wishbone sign in GM1 type III gangliosidosis
by: Ayush Agarwal, et al.
Published: (2023-01-01)

GM1 gangliosidosis: a case report
by: Guilherme Dienstmann, et al.
Published: (2021-11-01)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
by: Maria L. Allende, et al.
Published: (2023-12-01)

Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
by: Natalie M. Deschenes, et al.
Published: (2023-05-01)

An Evalution of the Demographic and Clinical Characterictics of Patients with GM2 Gangliosidosis
by: Esra Er, et al.
Published: (2018-03-01)

Case report: Preimplantation genetic testing for infantile GM1 gangliosidosis
by: Valeria A. Zagaynova, et al.
Published: (2024-02-01)

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
by: Jeyakumar, M, et al.
Published: (2003)

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.
by: Elliot-Smith, E, et al.
Published: (2008)

Single Institutional Experience with GM1 Gangliosidosis: Clinical and Laboratory Results of 14 Patients
by: Halil Tuna Akar, et al.
Published: (2022-09-01)

Clinical and imaging predictors of late‐onset GM2 gangliosidosis: A scoping review
by: Neha P. Godbole, et al.
Published: (2024-01-01)

Re: “Molecular analysis of 9 unrelated families presenting with juvenile and chronic GM1 gangliosidosis”
by: Carlos Eduardo Steiner, et al.
Published: (2024-02-01)

A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosisResearch in context
by: Pamela Kell, et al.
Published: (2023-06-01)

Enzyme-responsive polymersomes ameliorate autophagic failure in a cellular model of GM1 gangliosidosis
by: Bipin Chakravarthy Paruchuri, et al.
Published: (2022-10-01)

Characterization of a phenotypically severe animal model for human AB-Variant GM2 gangliosidosis
by: Natalie M. Deschenes, et al.
Published: (2023-11-01)

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
by: Kasperzyk, J, et al.
Published: (2004)

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
by: Kasperzyk, J, et al.
Published: (2004)

Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
by: Francesca Clemente, et al.
Published: (2022-06-01)

From amaurotic idiocy to biochemically defined lipid storage diseases: the first identification of GM1-Gangliosidosis
by: Burkhard S Kasper, et al.
Published: (2023-08-01)

From amaurotic idiocy to biochemically defined lipid storage diseases: the first identification of GM1-Gangliosidosis
by: Burkhard S Kasper, et al.
Published: (2023-08-01)

Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis
by: Toshiki Tsunogai, et al.
Published: (2022-12-01)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
by: Pshezhetsky, A, et al.
Published: (2017)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
by: Pshezhetsky, A, et al.
Published: (2017)

Ursodeoxycholic Acid Binds PERK and Ameliorates Neurite Atrophy in a Cellular Model of GM2 Gangliosidosis
by: Carolina Morales, et al.
Published: (2023-04-01)

Multimodal optical imaging and genetic features of AB variant GM2 gangliosidosis: a case report
by: Qin Chen, et al.
Published: (2023-05-01)

Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis
by: Meera Vyas, et al.
Published: (2023-09-01)

A propósito de un caso de gangliosidosis GM-2 tipo II: enfermedad de Sandhoff
by: Irelis González López, et al.
Published: (2015-06-01)

Altered GM1 catabolism affects NMDAR-mediated Ca2+ signaling at ER-PM junctions and increases synaptic spine formation in a GM1-gangliosidosis model
by: Jason A. Weesner, et al.
Published: (2024-05-01)

Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis
by: Jason Andrew Weesner, et al.
Published: (2022-08-01)

AAVrh10 vector corrects pathology in animal models of GM1 gangliosidosis and achieves widespread distribution in the CNS of nonhuman primates
by: Michaël Hocquemiller, et al.
Published: (2022-12-01)

"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
by: Kasperzyk, J, et al.
Published: (2005)

Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience
by: Rita Fischetto, et al.
Published: (2020-10-01)

The study on the prevalence of Mongolian spots in the neonates
by: Sabiha Quazi, et al.
Published: (2023-01-01)

Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann–Pick Type C
by: Claudia Capitini, et al.
Published: (2022-08-01)

Carrier Rate and Mutant Allele Frequency of GM1 Gangliosidosis in Miniature Shiba Inus (Mame Shiba): Population Screening of Breeding Dogs in Japan
by: Shahnaj Pervin, et al.
Published: (2022-05-01)

P134: Neuronal pathways by differential tractography correlate with clinical outcomes following gene therapy for GM1 gangliosidosis: New biomarker for neurodegenerative diseases*
by: Connor Lewis, et al.
Published: (2024-01-01)

Optimal management of hereditary hemorrhagic telangiectasia
by: Garg N, et al.
Published: (2014-10-01)

Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased <sup>1</sup>H NMR-Linked Metabolomics Strategy
by: Benita C. Percival, et al.
Published: (2021-03-01)

Erratum: Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice (Journal of Lipid Research (April 2004) 46 (744-751))
by: Kasperzyk, J, et al.
Published: (2005)

Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis
by: Sebastian Boland, et al.
Published: (2022-10-01)

Atypical Mongolian spots in an infant: A harbinger of lysosomal storage disorders
by: Manisha Varma Gadhiraju, et al.
Published: (2021-01-01)